| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2865177 | The American Journal of the Medical Sciences | 2010 | 5 Pages |
Abstract
This study suggests that intravenous administration of both sildenafil and BNP monotherapy produces significant improvement in RVSP, making them potentially viable options for the treatment of PAH, whereas combination therapy produces no additional improvement in pulmonary hemodynamics.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Carl MD, Rebecca I. BS, Kevin C. MD, PhD, Joseph D. MD, PhD, Randall L. BS, Vincent G. PhD, Ryan E. RRT, MHA, FACHE, Martin A. MD,